SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271
http://www.w3.org/2000/01/rdf-schema#comment
"Recombinant human erythropoietin treatment of endothelial cells causes a significant increase in asymmetric dimethylarginine (ADMA) levels in the cell culture medium."
xsd:string
http://purl.uniprot.org/uniprot/#_CF44CB5DA3C84475638F47AAD9293B96CD3BB9CCA38F951B847277775DADC4E64413BCEF7845A4A06B390699E9811BF7
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271
http://purl.uniprot.org/uniprot/U3MHQ9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271
http://purl.uniprot.org/uniprot/#_U3MHQ9-mappedCitation-15728783
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/08C43DB147F5C12FCF780BCE4D38ECEB99E12977D72CBD8121CF86665BCD19AE1C13E2CA95991EEF2E7AF292542B9271